Public release date: 14-Aug-2007

 

The new work examines the idea that methamphetamine puts young users at risk of developing deficits later in life that are symptomatic of Parkinson’s disease in individuals with depletion of glial derived neurotrophic factor (GDNF), a protein that protects and repairs dopamine in areas of the brain related to movement control. Loss of nerve cells that produce dopamine is a major factor in the disease.

Methamphetamine intoxication in any young adult may have deleterious consequences later in life, although they may not be apparent until many decades after the exposure,” says McGinty. “These studies speak directly to the possibility of long-term public health consequences resulting from the current epidemic of methamphetamine abuse among young adults.”

**Ralph’s Note – Medications that work along the same pathways. Should also be investigated.

Leave a Reply

Discover more from CLINICALNEWS.ORG

Subscribe now to keep reading and get access to the full archive.

Continue reading